Improved Feline Drugs as SARS-CoV-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization for Enhanced Bioavailability
收藏Protein Data Bank Japan2024-11-20 更新2026-03-21 收录
下载链接：
https://pdbj.org/mine/summary/7lco
下载链接
链接失效反馈官方服务：
资源简介：
Improved Feline Drugs as SARS-CoV-2 Mpro Inhibitors: Structure-Activity Studies & Micellar Solubilization for Enhanced Bioavailability Descriptor: (3-fluorophenyl)methyl [(2S)-3-cyclopropyl-1-oxo-1-({(2S)-1-oxo-3-[(3S)-2-oxopyrrolidin-3-yl]propan-2-yl}amino)propan-2-yl]carbamate, 3C-like proteinase Authors: Khan, M.B, Lu, J, Arutyunova, E, Young, H.S, Lemieux, M.J. Deposit date: 2021-01-11 Release date: 2021-07-07 Last modified: 2024-11-20 Method: X-RAY DIFFRACTION (1.9 Å) Cite: Improved SARS-CoV-2 M pro inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies. Eur.J.Med.Chem., 222, 2021
创建时间：
2021-01-11
